Impact of health policies on opioid tapering and discontinuation among patients receiving long-term opioid therapy for chronic noncancer pain
Open Access
- 14 March 2026
- journal article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 151, 105231
Abstract
No abstract availableKeywords
Funding Information
- Michael Smith Health Research BC (RT-2024-03845)
- Canadian Institutes of Health Research (PJT-156117)
- Canadian Institutes of Health Research (HIV-194093)
This publication has 26 references indexed in Scilit:
- Impact of COVID-19 Pandemic on Testing for Hepatitis B in British Columbia, Canada: An Interrupted Time Series AnalysisOpen Forum Infectious Diseases, 2025
- Incidence of Opioid Dose Tapering Among Older Adults Enrolled in MedicareInnovation in Aging, 2025
- Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysisInternational Journal of Drug Policy, 2024
- Trends in Opioid Toxicity–Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021JAMA Network Open, 2023
- Recent tapering from long‐term opioid therapy and odds of opioid‐related hospital usePharmacoepidemiology and Drug Safety, 2022
- Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose TaperingJAMA Network Open, 2022
- Evaluating the population‐level effects of oxycodone restrictions on prescription opioid utilization in OntarioPharmacoepidemiology and Drug Safety, 2022
- Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern StateDrug and Alcohol Dependence, 2021
- Abrupt Discontinuation of Long-term Opioid Therapy Among Medicare Beneficiaries, 2012–2017Journal of General Internal Medicine, 2021
- Use of Interrupted Time Series Analysis in Evaluating Health Care Quality ImprovementsAcademic Pediatrics, 2013